Is Century Therapeutics, Inc. (IPSC) a Buy, Sell, or Hold?
NASDAQ : IPSC
Century Therapeutics, Inc.
$2.25 USD
-$0.01 (-0.44%)
- Volume
- 1.1M
- Average Volume
- 1.28M
- Market Capitalization
- $194.78M
- P/E Ratio
- -1.80
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $3.04
- Year Low
- $0.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.25
Insider Activity Summary (Last 12 Months)
Insiders Buying
20
Insiders Selling
25
Amount of Insider Selling
$183.07K
IPSC Insider Buying/Selling by Quarter
IPSC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Russotti Gregory | officer: See Remarks | 2026-06-12 | S-Sale | 2.232 | 2026-06-15 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-06-12 | S-Sale | 2.232 | 2026-06-15 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-06-11 | F-InKind | 2.24 | 2026-06-15 |
| Cowan Chad | officer: Chief Scientific Officer | 2026-06-11 | F-InKind | 2.24 | 2026-06-15 |
| Riva Alessandro | director | 2026-06-11 | A-Award | 2.24 | 2026-06-12 |
| Quimi Daphne | director | 2026-06-11 | A-Award | 2.24 | 2026-06-12 |
| Murphy Martin Patrick | director | 2026-06-11 | A-Award | 2.24 | 2026-06-12 |
| Lee Han Myung | director | 2026-06-11 | A-Award | 2.24 | 2026-06-12 |
| Blackwell Kimberly | director | 2026-06-11 | A-Award | 2.24 | 2026-06-12 |
| Russotti Gregory | officer: See Remarks | 2026-06-08 | S-Sale | 2.111 | 2026-06-09 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-06-08 | S-Sale | 2.111 | 2026-06-09 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-06-05 | F-InKind | 2.13 | 2026-06-09 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-05-15 | F-InKind | 2.34 | 2026-05-19 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-05-04 | S-Sale | 2.341 | 2026-05-06 |
| Murphy Martin Patrick | director | 2025-12-09 | A-Award | 0.592 | 2026-04-10 |
| Murphy Martin Patrick | 2025-12-09 | 0 | 2026-04-10 | ||
| Cowan Chad | officer: Chief Scientific Officer | 2026-04-01 | F-InKind | 2.19 | 2026-04-03 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-03-12 | S-Sale | 2.549 | 2026-03-16 |
| Russotti Gregory | officer: See Remarks | 2026-03-12 | S-Sale | 2.549 | 2026-03-16 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-03-11 | F-InKind | 2.73 | 2026-03-13 |
| Cowan Chad | officer: Chief Scientific Officer | 2026-03-11 | F-InKind | 2.73 | 2026-03-13 |
| Russotti Gregory | officer: See Remarks | 2026-03-09 | S-Sale | 2.536 | 2026-03-11 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-03-06 | F-InKind | 2.56 | 2026-03-10 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-02-13 | F-InKind | 1.75 | 2026-02-18 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-02-03 | S-Sale | 1.822 | 2026-02-05 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-02-02 | A-Award | 0 | 2026-02-04 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2026-02-02 | A-Award | 1.84 | 2026-02-04 |
| Russotti Gregory | officer: See Remarks | 2026-02-02 | A-Award | 0 | 2026-02-04 |
| Russotti Gregory | officer: See Remarks | 2026-02-02 | A-Award | 1.84 | 2026-02-04 |
| Cowan Chad | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 0 | 2026-02-04 |
| Cowan Chad | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 1.84 | 2026-02-04 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-02-02 | A-Award | 0 | 2026-02-04 |
| Carr Douglas | officer: SVP Finance & Operations | 2026-02-02 | A-Award | 1.84 | 2026-02-04 |
| Cowan Chad | officer: Chief Scientific Officer | 2026-01-02 | F-InKind | 0.995 | 2026-01-06 |
| Cowan Chad | officer: Chief Scientific Officer | 2025-12-22 | P-Purchase | 0.8483 | 2025-12-29 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-12-12 | P-Purchase | 0.5837 | 2025-12-16 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-12-10 | F-InKind | 0.526 | 2025-12-12 |
| Lee Han Myung | director | 2025-12-09 | A-Award | 0.592 | 2025-12-11 |
| Lee Han Myung | 2025-12-09 | 0 | 2025-12-11 | ||
| Carr Douglas | officer: SVP Finance & Operations | 2025-12-08 | S-Sale | 0.532 | 2025-12-10 |
| Russotti Gregory | officer: See Remarks | 2025-12-08 | S-Sale | 0.532 | 2025-12-10 |
| Cowan Chad | officer: Chief Scientific Officer | 2025-11-20 | S-Sale | 0.501 | 2025-11-24 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-11-19 | P-Purchase | 0.4951 | 2025-11-20 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-11-17 | S-Sale | 0.454 | 2025-11-19 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-11-03 | S-Sale | 0.586 | 2025-11-05 |
| Cowan Chad | officer: Chief Scientific Officer | 2025-09-18 | A-Award | 0 | 2025-09-22 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-09-08 | S-Sale | 0.5 | 2025-09-10 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-09-08 | S-Sale | 0.5 | 2025-09-10 |
| Russotti Gregory | officer: See Remarks | 2025-09-08 | S-Sale | 0.5 | 2025-09-10 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-08-14 | A-Award | 0 | 2025-08-18 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-08-04 | S-Sale | 0.534 | 2025-08-06 |
| Blackwell Kimberly | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| JIMENEZ JOSEPH | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| Riva Alessandro | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| Carlo Rizzuto | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| Quimi Daphne | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| BUTITTA CYNTHIA M | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| Walbert Timothy P | director | 2025-06-12 | A-Award | 0.6 | 2025-06-16 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-06-09 | S-Sale | 0.622 | 2025-06-11 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-06-09 | S-Sale | 0.622 | 2025-06-11 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-06-09 | S-Sale | 0.622 | 2025-06-11 |
| Russotti Gregory | officer: See Remarks | 2025-06-09 | S-Sale | 0.622 | 2025-06-11 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-05-16 | S-Sale | 0.546 | 2025-05-20 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-05-05 | S-Sale | 0.55 | 2025-05-07 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-05-05 | S-Sale | 0.55 | 2025-05-07 |
| Conn Morgan | officer: Chief Finanical Officer | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Conn Morgan | officer: Chief Finanical Officer | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Cowan Chad | officer: Chief Scientific Officer | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Cowan Chad | officer: Chief Scientific Officer | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-03-10 | S-Sale | 0.615 | 2025-03-12 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Russotti Gregory | officer: See Remarks | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Russotti Gregory | officer: See Remarks | 2025-03-10 | S-Sale | 0.615 | 2025-03-12 |
| Russotti Gregory | officer: See Remarks | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-03-10 | S-Sale | 0.615 | 2025-03-12 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-03-11 | A-Award | 0 | 2025-03-12 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-03-10 | S-Sale | 0.615 | 2025-03-12 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-03-11 | A-Award | 0.601 | 2025-03-12 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2025-02-18 | S-Sale | 0.783 | 2025-02-20 |
| Farid Adrienne | officer: Chief Operations Officer | 2025-02-03 | S-Sale | 0.78 | 2025-02-05 |
| Carr Douglas | officer: SVP Finance & Operations | 2025-02-03 | S-Sale | 0.78 | 2025-02-05 |
| Pfeiffenberger Brent | director, officer: President and CEO | 2024-12-04 | F-InKind | 1.44 | 2024-12-06 |
| Farid Adrienne | officer: Chief Operations Officer | 2024-11-04 | S-Sale | 1.227 | 2024-11-05 |
| Carr Douglas | officer: SVP Finance & Operations | 2024-11-01 | F-InKind | 1.26 | 2024-11-05 |
| Carr Douglas | officer: SVP Finance & Operations | 2024-11-04 | S-Sale | 1.227 | 2024-11-05 |
| Conn Morgan | officer: Chief Finanical Officer | 2024-10-14 | A-Award | 1.48 | 2024-10-16 |
| Conn Morgan | officer: Chief Finanical Officer | 2024-10-14 | A-Award | 0 | 2024-10-16 |
| Conn Morgan | officer | 2024-10-14 | 0 | 2024-10-16 | |
| Cowan Chad | officer: Chief Scientific Officer | 2024-10-01 | A-Award | 1.65 | 2024-10-03 |
| Cowan Chad | officer: Chief Scientific Officer | 2024-10-01 | A-Award | 0 | 2024-10-03 |
| Cowan Chad | officer: Chief Scientific Officer | 2024-10-01 | 0 | 2024-10-03 | |
| Cowan Chad | officer: Chief Scientific Officer | 2024-10-01 | 0 | 2024-10-03 | |
| Quimi Daphne | director | 2024-09-12 | P-Purchase | 1.5314 | 2024-09-16 |
| Farid Adrienne | officer: Chief Operations Officer | 2024-08-05 | S-Sale | 1.827 | 2024-08-07 |
| Carr Douglas | officer: SVP Finance & Operations | 2024-08-05 | S-Sale | 1.827 | 2024-08-07 |
| Russotti Gregory | officer: See Remarks | 2024-07-26 | S-Sale | 2.5 | 2024-07-31 |
| Russotti Gregory | officer: See Remarks | 2024-07-23 | S-Sale | 2.5 | 2024-07-25 |